{
    "code": 0,
    "data": [
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On Thursday January 29 2026",
            "news_body": "Outcome of the Meeting of Board of Directors",
            "news_id": "00891014-827a-4e7a-8c14-39c7eeb5a9f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53a8685c-d3eb-4379-9287-5c17c2b75298.pdf",
            "news_date": "2026-01-29 13:04:37",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For Quarter And Half-Year Ended 30Th September 2025",
            "news_body": "Un-audited standalone and Consolidated Financial Results for quarter and half-year ended 30th September 2025",
            "news_id": "8ca4a2c4-006a-411b-b535-dd2a28827057",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee3e4729-f9b9-4769-bd90-bb7697fabedb.pdf",
            "news_date": "2025-11-11 12:17:52",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On August 13 2025",
            "news_body": "Financial Results Q1 FY 2025-26",
            "news_id": "b9341529-8cf8-45e7-abcb-e1f83ac78a5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=774615df-d0c7-4863-94cf-5329f3819b82.pdf",
            "news_date": "2025-08-13 12:52:43",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On Tuesday May 13 2025",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "750ccbaf-3dd9-4b09-af55-2d72d5a1f7b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4adfffe6-a28c-4a70-b253-6033aeeeaa24.pdf",
            "news_date": "2025-05-13 16:01:23",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Unaudited standalone & consolidated financial results for quarter ended December 31 2024",
            "news_id": "d9a28aff-e4f2-4a2b-856c-9e796fb3bede",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5bfb90b-5201-437c-8a58-0283a6c041da.pdf",
            "news_date": "2025-01-24 16:18:32",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting - Financial Results For Quarter & Half-Year Ended 30/09/2024",
            "news_body": "Financial results for quarter & half-year ended 30/09/2024",
            "news_id": "ddcc9384-44b4-4bdc-b729-38c5714fb9de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b56badf-d825-4a5a-a0c6-0a5caec32916.pdf",
            "news_date": "2024-10-29 12:51:52",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Unaudited Standalone & Consolidated financial results for quarter ended June 30, 2024",
            "news_id": "1de71341-5ec5-4e28-b6e0-3491904d7970",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26dc718e-99e0-4b07-99f5-a3b4c3e1a5fc.pdf",
            "news_date": "2024-08-05 13:12:52",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approved The Attached Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2024",
            "news_id": "d32b710a-1a1e-4485-9d73-5a58e7fac41e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=834c95fc-b65b-4e7d-b890-4be7a02eebd6.pdf",
            "news_date": "2024-05-06 18:45:23",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results Under Ind AS For Quarter And Ended December 31, 2023",
            "news_body": "Outcome of the Board Meeting Q3 Results FY 2023-24",
            "news_id": "b83ebf09-d5df-4a3f-b30d-2f7011d4075f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60d00048-5048-4c7e-a0e6-45f8b7e46e20.pdf",
            "news_date": "2024-01-30 12:57:51",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company Under Ind AS Along With Review Reports Of The Statutory Auditors For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Enclosed Unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2023",
            "news_id": "284ffaf5-2455-4c3b-9ff6-1e9c5512f8d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77de3071-a394-487c-8363-b0d225b27606.pdf",
            "news_date": "2023-11-04 12:41:20",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended 30Th June, 2023.",
            "news_body": "Outcome of Board Meeting",
            "news_id": "e3ccffed-a011-42f1-964a-63c34630e4c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4f93b7c-61aa-4ac5-92e6-e5457423af9e.pdf",
            "news_date": "2023-08-08 13:02:56",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Prepared Under Ind AS For The Quarter And Financial Year Ended 31St March, 2023",
            "news_body": "With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 09, 2023, approved the following along with other business matters.<BR> <BR> Took on record and approved the Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and Financial Year ended 31st March, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors.  <BR>",
            "news_id": "f7ee6ba4-1f53-46d7-820e-e89fceffc280",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b6f5a40-22ec-48f4-9346-8b3b20dad183.pdf",
            "news_date": "2023-05-09 13:14:52",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended December 31, 2022.",
            "news_body": "With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company at its meeting held today i.e. February 02, 2023, has taken on record and approved Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended December 31, 2022.<BR> We are enclosing herewith the following documents:<BR> a) Un-audited Standalone and Consolidated Financial Results under Ind AS for quarter ended December 31, 2022. <BR> b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and<BR> c) A copy of the News Release of our company<BR> Update on patents during this period are accessible to everyone at below mentioned web link: www.suven.com/Patentupdates.aspx",
            "news_id": "05bce8bc-5c18-48a0-a349-61e9d98f9301",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9b059b2-b987-46b4-892d-5d63b0178b24.pdf",
            "news_date": "2023-02-02 13:46:56",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Sub: Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions and balances for the half year ended September 30th, 2022.",
            "news_id": "8e454fbc-c039-4593-a33d-a3cd51fea6db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=407dc8de-0776-4319-8792-208fc5eb8851.pdf",
            "news_date": "2022-11-22 15:35:28",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company at its meeting held today i.e. November 10, 2022, has taken on record and approved Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter and half-year ended September 30, 2022.",
            "news_id": "26907ce1-7bbf-486f-8a34-df73d414441c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=381939d6-c757-4c76-9d52-f686d230ac44.pdf",
            "news_date": "2022-11-10 17:14:56",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Under Ind AS For Quarter Ended 30Th June, 2022",
            "news_body": "With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company at its meeting held today i.e. 26th July, 2022, has taken on record and approved Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended 30th June, 2022.<BR> <BR> We are enclosing herewith the following documents:<BR> a) Un-audited Standalone and Consolidated Financial Results under Ind AS for quarter ended 30th June, 2022.<BR> b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and<BR> c) A copy of the News Release of our company",
            "news_id": "34a0d98f-d737-4e96-b405-b67bccda658d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=761d4fcb-c95d-422e-9804-9be0010ef92b.pdf",
            "news_date": "2022-07-26 13:26:24",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9)",
            "news_body": "Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions and balances for the half year ended March 31st, 2022.",
            "news_id": "c453e210-e1c6-4a19-99d8-dd4c16a56478",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f57726b-334a-46a8-b174-b1f680e04e6f.pdf",
            "news_date": "2022-05-20 15:21:56",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Prepared Under Ind AS For The Quarter And Financial Year Ended 31St March, 2022",
            "news_body": "1) Took on record and approved the Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and Financial Year ended 31st March, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors.",
            "news_id": "ef0a18ab-1f27-4568-b2dd-97ee68913550",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57507814-a81e-4163-a8a1-cc1b12caae14.pdf",
            "news_date": "2022-05-07 13:25:05",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31St December, 2021",
            "news_body": "With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 31st January, 2022, has taken on record and approved the   Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended 31st December, 2021.<BR> <BR> We are enclosing herewith the following documents:<BR> a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter ended 31st December, 2021.<BR> b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and<BR> c) A copy of the News Release of our company<BR> <BR> Update on patents during this period can be viewed at: http://www.suven.com/Patentupdates.aspx<BR> <BR> We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:15 P.M.",
            "news_id": "63ba0ba4-7046-4b27-9e17-a9fcbd7b2290",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9123d6cb-32a2-4d14-9510-7ad6850fb67d.pdf",
            "news_date": "2022-01-31 12:40:34",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results Under Ind AS For The Quarter And Half-Year Ended 30Th September, 2021.",
            "news_body": "We are enclosing herewith the following documents:<BR> a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter and half-year ended 30th September, 2021.<BR> b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and<BR> c) A copy of the News Release of our company<BR> <BR> Update on patents during this period can be viewed at: http://suven.com/Patentupdates.aspx<BR> <BR> We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:45 P.M.<BR>",
            "news_id": "9f1ab9c5-831a-490e-a1d0-1ec0164352cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe4075b1-2783-4165-a031-2373ad78d1a0.pdf",
            "news_date": "2021-10-25 13:07:59",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2021.",
            "news_body": "With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 09th August, 2021, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended 30th June, 2021.  <BR> <BR> We are enclosing herewith the following documents:<BR> a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter ended 09th August, 2021.<BR> b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and<BR> c) A copy of the News Release of our company<BR> <BR> Update on patents during this period can be viewed at: http://suven.com/Patentupdates.aspx<BR> <BR> We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:30 P.M.",
            "news_id": "ca0ec183-25ed-4894-92e2-b4a7251a8068",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fee7371a-2655-48c3-88c9-ac85f6752a70.pdf",
            "news_date": "2021-08-09 13:16:52",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2021",
            "news_body": "With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 09th August, 2021, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended 30th June, 2021.<BR> <BR> We are enclosing herewith the following documents:<BR> a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter ended 09th August, 2021.<BR> b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and<BR> c) A copy of the News Release of our company<BR> <BR> Update on patents during this period can be viewed at: http://suven.com/Patentupdates.aspx<BR> <BR> We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:30 P.M.",
            "news_id": "edfe7783-8e11-44cb-8683-cfe5ab380967",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=890feb6f-97bd-48a5-bd51-e8af85d5839a.pdf",
            "news_date": "2021-08-09 12:57:33",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions on a consolidated basis and balances for the year ended March 31st, 2021.<BR> We request you to take this document on your record.",
            "news_id": "ba30986d-7fbe-41c1-a5b1-68eba10c2b7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fec9220-4166-49f7-8f04-4607bb2a31c3.pdf",
            "news_date": "2021-05-20 14:59:02",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUVEN",
            "disp": "Suven Life Sciences",
            "bse_code": 530239,
            "isin": "INE495B01038",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 04, 2021, approved the following along with other business matters.<BR>  <BR>",
            "news_id": "0c5b8fd1-e9d7-4150-9125-c99ca0f267d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=221f8053-b542-43d2-bd6f-31359f78f4bd.pdf",
            "news_date": "2021-05-04 13:15:53",
            "seo": "suven-life-sciences-ltd",
            "ltp": 156.88,
            "ch": -1.539999999999992,
            "pch": -0.9720994823885825,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11233,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}